FDA Approves Expanded Access Program For Lipella Pharma's LP-310 In Oral Lichen Planus ...
Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company, Wednesday said that the U.S. Food and Drug ...
FDA approves Lipella's oral treatment access program
PITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ:LIPO), a biotech firm specializing in novel therapies for medical conditions lacking adequate treatments, has received FDA approval for an Expanded ...
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral ...
Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on ...
Oral cancer no longer a smokers’ disease, reveals study
KOCHI: A recent study conducted by the head and neck department of Kochi-based VPS Lakeshore Hospital showed that there is a ...